Ra Capital Management as of June 30, 2022
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 88 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 18.8 | $704M | 7.6M | 92.96 | |
| Biogen Idec (BIIB) | 4.0 | $148M | 727k | 203.94 | |
| Cytek Biosciences (CTKB) | 3.8 | $144M | 13M | 10.73 | |
| Aerovate Therapeutics (AVTE) | 3.4 | $129M | 8.3M | 15.63 | |
| Day One Biopharmaceuticals I (DAWN) | 3.4 | $126M | 7.0M | 17.90 | |
| Travere Therapeutics (TVTX) | 3.2 | $119M | 4.9M | 24.23 | |
| Janux Therapeutics (JANX) | 2.8 | $106M | 8.7M | 12.21 | |
| Vaxcyte (PCVX) | 2.7 | $100M | 4.6M | 21.76 | |
| ImmunoGen | 2.6 | $98M | 22M | 4.50 | |
| Nkarta (NKTX) | 2.6 | $96M | 7.8M | 12.32 | |
| Bellus Health Com New | 2.5 | $95M | 10M | 9.24 | |
| Iteos Therapeutics (ITOS) | 2.4 | $91M | 4.4M | 20.60 | |
| Female Health (VERU) | 2.4 | $89M | 7.9M | 11.30 | |
| Dice Therapeutics | 2.2 | $81M | 5.2M | 15.52 | |
| Pepgen (PEPG) | 2.2 | $81M | 8.1M | 9.93 | |
| Forma Therapeutics Hldgs SHS | 1.7 | $62M | 9.0M | 6.89 | |
| Aclaris Therapeutics (ACRS) | 1.6 | $61M | 4.4M | 13.96 | |
| Point Biopharma Global | 1.6 | $61M | 9.0M | 6.81 | |
| Celldex Therapeutics Com New (CLDX) | 1.5 | $56M | 2.1M | 26.96 | |
| Wave Life Sciences SHS (WVE) | 1.5 | $56M | 17M | 3.25 | |
| Vor Biopharma (VOR) | 1.5 | $55M | 11M | 4.97 | |
| Kinnate Biopharma | 1.4 | $54M | 4.3M | 12.61 | |
| Tyra Biosciences (TYRA) | 1.4 | $52M | 7.2M | 7.15 | |
| Gh Research Ordinary Shares (GHRS) | 1.3 | $49M | 4.9M | 9.98 | |
| Geron Corporation (GERN) | 1.2 | $47M | 30M | 1.55 | |
| Natera (NTRA) | 1.2 | $46M | 1.3M | 35.44 | |
| Acumen Pharmaceuticals (ABOS) | 1.2 | $46M | 9.8M | 4.70 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $46M | 3.6M | 12.70 | |
| Rxsight (RXST) | 1.1 | $43M | 3.1M | 14.08 | |
| Enanta Pharmaceuticals (ENTA) | 1.1 | $42M | 897k | 47.27 | |
| Eliem Therapeutics (CLYM) | 1.1 | $40M | 13M | 3.02 | |
| Relmada Therapeutics (RLMD) | 1.0 | $38M | 2.0M | 18.99 | |
| Instil Bio | 0.9 | $35M | 7.7M | 4.62 | |
| Icosavax | 0.9 | $34M | 6.0M | 5.73 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $32M | 2.2M | 14.53 | |
| Design Therapeutics (DSGN) | 0.8 | $31M | 2.2M | 14.00 | |
| An2 Therapeutics (ANTX) | 0.8 | $29M | 3.7M | 7.75 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $29M | 2.1M | 13.76 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $27M | 3.4M | 7.87 | |
| 89bio (ETNB) | 0.7 | $25M | 7.8M | 3.22 | |
| Satsuma Pharmaceuticals Ord | 0.7 | $25M | 5.9M | 4.14 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $24M | 1.7M | 14.25 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $22M | 1.6M | 13.61 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $21M | 5.1M | 4.19 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $20M | 4.9M | 4.15 | |
| Tenaya Therapeutics (TNYA) | 0.5 | $20M | 3.6M | 5.63 | |
| Dyne Therapeutics (DYN) | 0.5 | $19M | 2.8M | 6.87 | |
| Hillevax (HLVX) | 0.5 | $19M | 1.8M | 10.93 | |
| Guardant Health (GH) | 0.5 | $19M | 476k | 40.34 | |
| Pardes Biosciences | 0.5 | $19M | 6.2M | 3.07 | |
| Werewolf Therapeutics (HOWL) | 0.5 | $18M | 4.3M | 4.09 | |
| Da32 Life Scnce Class A Com | 0.4 | $15M | 1.5M | 9.69 | |
| Concert Pharmaceuticals I equity | 0.4 | $14M | 3.3M | 4.21 | |
| Milestone Pharmaceuticals (MIST) | 0.4 | $14M | 2.2M | 6.15 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $13M | 5.0M | 2.52 | |
| Bcls Acquisition Corp Com Cl A | 0.3 | $12M | 1.3M | 9.90 | |
| Otonomy | 0.3 | $12M | 5.6M | 2.08 | |
| Lianbio Sponsored Ads (LIANY) | 0.3 | $10M | 4.6M | 2.16 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.3 | $9.9M | 1.0M | 9.87 | |
| Arya Sciences Acquisitn Class A Ord Shs | 0.3 | $9.7M | 1.0M | 9.72 | |
| Relay Therapeutics (RLAY) | 0.2 | $9.2M | 549k | 16.75 | |
| Io Biotech (IOBT) | 0.2 | $8.7M | 1.9M | 4.67 | |
| Solid Biosciences | 0.2 | $7.6M | 12M | 0.62 | |
| 5 01 Acquisition Corp Com Cl A | 0.2 | $7.4M | 750k | 9.90 | |
| Synlogic | 0.2 | $6.7M | 5.8M | 1.15 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $6.4M | 2.6M | 2.46 | |
| Century Therapeutics (IPSC) | 0.2 | $6.4M | 757k | 8.40 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.2 | $6.2M | 625k | 9.96 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $6.1M | 7.0M | 0.87 | |
| Biomea Fusion (BMEA) | 0.2 | $6.0M | 500k | 11.98 | |
| Athira Pharma (ATHA) | 0.2 | $5.7M | 1.9M | 3.05 | |
| Xilio Therapeutics (XLO) | 0.1 | $4.8M | 1.6M | 2.92 | |
| Aadi Bioscience (AADI) | 0.1 | $4.7M | 383k | 12.32 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $3.2M | 2.0M | 1.60 | |
| Entera Bio SHS (ENTX) | 0.1 | $3.1M | 2.4M | 1.33 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $3.1M | 1.3M | 2.48 | |
| Bioatla (BCAB) | 0.1 | $2.9M | 1.0M | 2.85 | |
| Astria Therapeutics (ATXS) | 0.1 | $2.3M | 761k | 3.00 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $2.3M | 953k | 2.38 | |
| Adverum Biotechnologies | 0.1 | $2.1M | 1.7M | 1.20 | |
| Larimar Therapeutics (LRMR) | 0.1 | $2.0M | 1.0M | 1.96 | |
| Orchard Therapeutics Ads | 0.0 | $1.8M | 3.0M | 0.58 | |
| CVRX (CVRX) | 0.0 | $1.7M | 275k | 6.01 | |
| Sensei Biotherapeutics (SNSE) | 0.0 | $1.6M | 724k | 2.27 | |
| Olema Pharmaceuticals (OLMA) | 0.0 | $952k | 234k | 4.07 | |
| Bolt Biotherapeutics (BOLT) | 0.0 | $918k | 450k | 2.04 | |
| Avrobio Ord (AVRO) | 0.0 | $515k | 560k | 0.92 | |
| Caladrius Biosciences Ord | 0.0 | $399k | 753k | 0.53 |
